Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

Share Price is delayed by 15 minutes
Get Live Data
2.51    -0.19 (-7.04%)
Bid:
2.50
Ask:
2.69
Spread: 0.19 (7.60%)
Market Cap: £2.59m
LIT Live PriceLast checked at - London Stock Exchange

Intraday Litigation Cap. Share Chart

Share Buyback Programme

5 Oct 2023 07:00

RNS Number : 7215O
Litigation Capital Management Ltd
05 October 2023
 

05 October 2023

 

Litigation Capital Management Limited

("LCM" or the "Company")

 

Share Buyback Programme

 

Litigation Capital Management Limited (AIM:LIT), an alternative asset manager specialising in dispute financing solutions internationally, today announces that it intends to commence a share buyback programme in respect of its ordinary shares up to a maximum consideration of A$10.0 million from the date of this announcement (the "Share Buyback Programme").

The purpose of the Share Buyback Programme is to reduce the share capital of the Company in order to return value to shareholders.

The Share Buyback Programme was first announced in the full year audited results for the year ended 30 June 2023 released on 19 September 2023.

LCM has entered into an irrevocable non-discretionary instruction with Canaccord Genuity Limited ("Canaccord") in relation to the purchase by Canaccord, acting as principal during the period commencing on 5th October 2023 and ending upon the publication of the full year audited results of the Company for the year ended 30th June 2024, of Ordinary Shares for an aggregate consideration (excluding expenses) of no greater than A$10.0 million and the simultaneous on-sale of such Ordinary Shares by Canaccord to LCM, where they will be held in treasury. Canaccord will make its trading decisions concerning the timing of the purchases of Ordinary Shares independently of, and uninfluenced by, the Company.

The Share Buyback Programme will be conducted within certain pre-set parameters, and in accordance with Chapter 12 of the UK Listing Rules and the provisions of the Market Abuse Regulation 596/2014/EU as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019 ("UK MAR") and the Commission Delegated Regulation 2016/1052/EU as amended by Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019 which both form part of the law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018. Notwithstanding the average daily volume restrictions set out in Article 3(3) (b) of the Commission Delegated Regulation (EU) 2016/1052, the Company may make purchases in excess of these volume restrictions, subject to prevailing market conditions and liquidity.

 

Enquiries

 

Litigation Capital Management

c/o Tavistock

Patrick Moloney, Chief Executive Officer

Mary Gangemi, Chief Financial Officer

 

 

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

 

Tavistock (PR and IR)

Tel: 020 7920 3150

Tim Pearson

Katie Hopkins

lcm@tavistock.co.uk

 

NOTES TO EDITORS

Litigation Capital Management (LCM) is an alternative asset manager specialising in disputes financing solutions internationally, which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is third party fund management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Portfolio funding and Acquisitions of claims. LCM generates its income from both its direct investments and also performance fees through asset management.

 

LCM has an unparalleled track record driven by disciplined project selection and robust risk management. Currently headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFSLFILEDSEES
Date   Source Headline
31st Oct 20247:00 amRNSTransaction in Own Shares
30th Oct 20247:00 amRNSExercise of Awards
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
28th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSExercise of Awards
18th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:01 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSChange of Nominated Adviser and Broker
14th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 202411:32 amRNSResult of AGM
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 202411:55 amRNSPositive update on Fund I investment
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20247:00 amRNSTransaction in Own Shares
27th Sep 20247:01 amRNSTransaction in Own Shares
27th Sep 20247:00 amRNSDividend currency entitlement
25th Sep 20247:00 amRNSTransaction in Own Shares
24th Sep 20247:00 amRNSTransaction in Own Shares
20th Sep 20247:00 amRNSTransaction in Own Shares
19th Sep 20247:00 amRNSTransaction in Own Shares
18th Sep 20247:00 amRNSTransaction in Own Shares
17th Sep 20246:05 pmRNSDividend Date
17th Sep 20245:20 pmRNSNotice of AGM
17th Sep 20247:01 amRNSTransaction in Own Shares
17th Sep 20247:00 amRNSFull year audited results for the YE 30 June 2024
13th Sep 20247:00 amRNSTransaction in Own Shares
11th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20242:25 pmRNSResignation of Director
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 20247:00 amRNSTransaction in Own Shares
30th Aug 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
23rd Aug 20247:00 amRNSTransaction in Own Shares
22nd Aug 20247:00 amRNSTransaction in Own Shares
21st Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:01 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.